Scinovex
Subscribe
M

Manjula Shantaram

Mangalore University (IN)ORCID 0000-0002-3874-4465
h-index
17
Publications
176
Citations
823
i10-index
21
Impact (2-yr)
1.73
Citations per year
Research Areas
Medicinal Plants and NeuroprotectionDiabetes Treatment and ManagementNatural Antidiabetic Agents StudiesCholinesterase and Neurodegenerative DiseasesPharmacology and Obesity Treatment
Affiliations
Vels University
IN · 2024–2024
Yenepoya University
IN · 2009–2023
Mangalore University
IN · 2015–2026
Graduate Hospital
US · 2022–2022
Piedmont Newnan Hospital
US · 2020–2020
Shamnur Shivashankarappa Institute of Medical Sciences & Research Centre
IN · 2024–2026
Hadhramout University
YE · 2024–2024
Mangalore Institute of Oncology
IN · 2026–2026

Top Publications

Practice of traditional medicinal plants in humans and cattle in Arasikere hobli of Karnataka
Journal of Medicinal Plants Studies20174 citations
Expert opinion on fixed-dose combinations of sitagliptin + dapagliflozin and the triple drug combination of dapagliflozin + sitagliptin + metformin in the management of type 2 diabetes mellitus in Indian settings
International Journal of Advanced Research in Medicine20241 citationsFirst authorCorresponding
Expert opinion on the prescription practices of silodosin and combination therapies in the management of benign prostatic hyperplasia in Indian settings
International Journal of Urology Research20241 citationsFirst authorCorresponding
Expert perspectives on the use of sacubitril/valsartan for managing heart failure in Indian settings
International Journal of Cardiology Sciences20250 citationsFirst authorCorresponding
Experts' perspective on the prescription of dapagliflozin for treating T2DM patients in Indian settings
International Journal of Endocrinology Research20250 citationsFirst authorCorresponding
Clinician’s perspectives and preferences in the management of benign prostatic hyperplasia in Indian settings
International Journal of Urology Research20250 citationsFirst authorCorresponding
Prescription trends of aceclofenac as a standalone or in combination with paracetamol for managing arthritis in Indian settings
International Journal of Orthopaedics Sciences20250 citationsFirst authorCorresponding
Expert opinion on glimepiride, pioglitazone, and metformin fixed-dose combination in Type 2 Diabetes Mellitus patients: The results of One Pride study
International Journal of Diabetes Sciences20240 citationsFirst authorCorresponding
Expert opinion on the use of SGLT2 inhibitors and its combination with a special focus on dapagliflozin in the management of type 2 diabetes in Indian settings
International Journal of Endocrinology Sciences20240 citationsFirst authorCorresponding
Expert opinion on the preferences and practices of sitagliptin in type 2 diabetes management in Indian settings
International Journal of Diabetes Research20250 citationsFirst authorCorresponding
Expert’s preference on escitalopram and clonazepam for treating depression and anxiety in Indian diabetic and hypertensive patients
International Journal of Research in Psychiatry20240 citationsFirst authorCorresponding
Expert opinion on the use of vildagliptin + dapagliflozin + metformin triple combination for managing uncontrolled type 2 diabetes mellitus in Indian settings
International Journal of Diabetes Research20240 citationsFirst authorCorresponding
Expert perspectives on the use of a triple combination of voglibose, glimepiride and metformin for the management of diabetes in Indian settings
International Journal of Endocrinology Research20240 citationsFirst authorCorresponding
Clinicians perspectives and practices regarding the use of sitagliptin, dapagliflozin, and metformin fixed-dose combination for managing type 2 diabetes in India
International Journal of Diabetes Sciences20250 citationsFirst authorCorresponding
Manjula Shantaram · Scinovex